News

Blood test diagnoses Alzheimer’s with over 90% accuracy

The detection of phosphorylated TAU 217 protein (p-tau217) in plasma has shown high precision in identifying pathological accumulations of beta-amyloid and TAU proteins. This precision is comparable t...

Success at Sant Pau’s research support platforms open day

This week, the research support platforms of the Sant Pau Research Institute opened their doors to researchers and management staff in an initiative aimed at fostering collaboration and promoting the ...

Sant Pau initiates the second clinical trial on the long-term effects of deep brain stimulation (DBS) in patients with ultra-resistant schizophrenia to treatment

Sant Pau continues to lead in the treatment of pharmacoresistant schizophrenia with deep brain stimulation (DBS) worldwide. After performing the first intervention of this kind in 2014 and publishing ...

S’s Scientific-Technical Service Platforms successfully achieve ISO 9001 audit

Once again, the Scientific-Technical Service Platforms (PSCT) of the Sant Pau Research Institute and Sant Pau Hospital have successfully passed the ISO 9001 Quality Management System audit, demonstrat...

The Sant Pau Research Day on genomics and rare diseases was successfully celebrated today

Today, we celebrated the Sant Pau Research Day with genomics and rare diseases taking center stage. The day began with an introduction by Dr. Xavier Prats Monné, president of the board of the Sant Pa...